Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Autoimmune Disease Increases Risk of Developing Cardiovascular Disease
August 29th 2022Although investigations have been performed on the association between inflammatory conditions and cardiovascular events, the effect of different conditions on cardiovascular diseases has not been analyzed on a large scale.
Read More
Patients with PsA More Likely to Experience Side Effects of Methotrexate
August 26th 2022"This risk-to-benefit profile has a different connotation for patients because, although a therapy may improve certain aspects of their disease, it may also have a substantial impact on their quality of life.”
Read More
Paul M Peloso, MD, MSc: Izokibep Significantly Improves Symptoms of Psoriatic Arthritis
August 25th 2022Rheumatology Network interviewed Paul M. Peloso, MD, MSc, Chief Medical Officer at Acelyrin, to discuss recent phase 2 data examining the safety and efficacy of izokibep in the treatment of psoriatic arthritis.
Read More
Pulmonary Involvement More Likely in Treatment-Naïve Pediatric Patients
August 24th 2022Although pulmonary complications in pediatric patients may cause functional impairment and increase mortality, studies detecting lung involvement in children with treatment-naïve, newly diagnosed patients with rheumatic disease are scarce.
Read More
FDA Approves Citrate-Free, High-Concentration Adalimumab Biosimilar Adalimumab-bwwd
August 17th 2022The US Food and Drug Administration approved of the citrate-free, high-concntration (100 mg/mL) formulation of adalimumab-bwwd, a biosimilar of adalimumab, for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
Read More
Psoriatic Arthritis Remission Strongly Associated with Alleviation of Psoriasis Symptoms
August 16th 2022“Given the complex nature of PsA, patients should also be involved in defining their treatment goals, as every patient may have different perspectives on the target for therapy and the means to achieve it.”
Read More
COVID-19 Vaccine Minimally Impacts Risk of Gout Flares
August 11th 2022"COVID-19 vaccines are effective against severity of SARS-COV-2 infection, but there has been a concern regarding their effect on the risk of flares in patients with gout, which are associated with health-related quality of life, healthcare resource utilization, and work productivity."
Read More